GlaxoSmithKline has poached a key vaccine executive from Pfizer, as the UK drugmaker makes a big bet on the future of mRNA technology. Philip Dormitzer will this week join GSK as global head…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
AcceptRead More